Statistics for Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
Total visits
views | |
---|---|
Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus | 356 |
Total visits per month
views | |
---|---|
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
File Visits
views | |
---|---|
CCRP.2015.831260.pdf | 301 |
CCRP.2015.831260.xml | 70 |
Top country views
views | |
---|---|
United States | 177 |
Canada | 51 |
Germany | 35 |
Ireland | 15 |
China | 9 |
Finland | 5 |
United Kingdom | 4 |
Vietnam | 3 |
France | 2 |
Cyprus | 1 |
Estonia | 1 |
Japan | 1 |
Nigeria | 1 |
Singapore | 1 |
Top city views
views | |
---|---|
Ashburn | 142 |
Winnipeg | 43 |
Dublin | 15 |
Inglewood | 6 |
Brooklyn | 5 |
Steinbach | 5 |
Beijing | 4 |
Hanoi | 3 |
Helsinki | 3 |
Burton-on-Trent | 2 |
Landshut | 2 |
Offenburg | 2 |
Seattle | 2 |
Zhengzhou | 2 |
Ann Arbor | 1 |
Boardman | 1 |
Chandler | 1 |
Chicago | 1 |
Des Moines | 1 |
Frankfurt am Main | 1 |
Halifax | 1 |
Heidelberg | 1 |
Kingston | 1 |
Lagos | 1 |
Los Angeles | 1 |
Mannheim | 1 |
Morlenbach | 1 |
Mountain View | 1 |
Mudau | 1 |
Nagold | 1 |
Phoenix | 1 |
Shanghai | 1 |
Shenyang | 1 |
Singapore | 1 |
Tokyo | 1 |
Vechta | 1 |
Winkler | 1 |